OpGen Inc
NASDAQ:OPGN

Watchlist Manager
OpGen Inc Logo
OpGen Inc
NASDAQ:OPGN
Watchlist
Price: 20 USD Market Closed
Market Cap: $201.4m

Net Margin

172.8%
Current
Improving
by 882.2%
vs 3-y average of -709.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
172.8%
=
Net Income
$15.6m
/
Revenue
$9m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
172.8%
=
Net Income
$15.6m
/
Revenue
$9m

Peer Comparison

Country Company Market Cap Net
Margin
US
OpGen Inc
NASDAQ:OPGN
201.4m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 99% of companies in the United States of America
Percentile
99th
Based on 15 072 companies
99th percentile
172.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

OpGen Inc
Glance View

Market Cap
201.4m USD
Industry
Biotechnology

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The company is headquartered in Rockville, Maryland and currently employs 99 full-time employees. The company went IPO on 2015-05-05. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes the Curetis Unyvero System and multiplex syndromic panels, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb using next generation sequencing (NGS) technology and Artificial intelligence (AI) powered bioinformatics solutions for antibiotic response prediction, as well as the Curetis CE vitro diagnostic (IVD) marked polymerase chain reaction (PCR) based severe acute respiratory syndrome (SARS) CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

OPGN Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
172.8%
=
Net Income
$15.6m
/
Revenue
$9m
What is OpGen Inc's current Net Margin?

The current Net Margin for OpGen Inc is 172.8%, which is above its 3-year median of -709.4%.

How has Net Margin changed over time?

Over the last 3 years, OpGen Inc’s Net Margin has increased from -796.7% to 172.8%. During this period, it reached a low of -1 430% on Dec 31, 2022 and a high of 218.5% on Dec 31, 2024.

Back to Top